Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 6, 1998, Pages 605-612

  Naim, Karen L ^a   Rabindranauth, Prem ^a   Weiss, Harvey R ^a   Tse, James ^a   Leone Jr , Richard J ^a   Scholz, Peter M ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Coronary blood flow; Dog; Guanylate cyclase; Myocardial O2 consumption; Myocardial shortening; Myocardial work

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; ISOPRENALINE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE HYPERTROPHY; HEART WEIGHT; HEART WORK; INOTROPISM; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0032469880     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-073     Document Type: Article

References (31)

1. Brady, A.B., Warren, J.B., Poole-Wilson, P., Williams, T., and Harding, S.E. 1993. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265: H176-H182.
2. Fischmeister, R., and Hartzell, H.C. 1987. Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J. Physiol. (London), 387: 453-472.
3. Guo, X., Kedem, J., Weiss, H.R., Tse, J., Roitstein, A., and Scholz, P.M. 1996. Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy. J. Cardiovasc. Pharmacol. 27: 392-400.
4. 2+ current in single heart cells. Nature (London), 323: 273-275.
5. Hilal-Dandan, R., and Khairalla, P.A. 1991. Cyclic AMP in myocytes isolated from hypertrophied rat hearts. J. Mol. Cell. Cardiol. 23: 705-716.
6. Kedem, J., Lee, W., and Weiss, H.R. 1994. An experimental technique for quantitative determination of regional myocardial segment work in vivo. Ann. Biomed. Eng. 22: 58-65.
7. Levi, R.C., Alloatti, G., and Fischmeister, R. 1989. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pfluegers Arch. 413: 685-687.
8. Lohmann, S.M., Fischmeister, R., and Walter, U. 1991. Signal transduction by cGMP in heart. Basic Res. Cardiol. 86: 503-514.
9. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 88: 1197-1201.
10. Morgan, H.E. 1993. Cellular aspects of cardiac failure. Circulation, 87(Suppl. 5): IV4-IV6.
11. Nichols, J.R., and Gonzalez, N.C. 1982. Increase in myocardial cell cGMP concentration in pressure-induced myocardial hypertrophy. J. Mol. Cell. Cardiol. 14: 181-183.
12. Picq, M., Dubois, M., Grynberg, A., Lagarde, M., and Prigent, A.F. 1996. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 28: 2151-2161.
13. Rivetbastide, M., Vandecasteele, G., Hatem, S., Verde, I., Benardeau, A., Mercadier, J.J., and Fischmeister, R. 1997. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J. Clin. Invest. 99: 2710-2718.
14. Roitstein, A., Kedem, J., Cheinberg, B., Weiss, H.R., Tse, J., and Scholz, P.M. 1994. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. J. Surg. Res. 57: 584-590.
15. 2 consumption in control but not renal hypertension-induced cardiac hypertrophy. Cardiovasc. Res.
16. Scholz, P.M., Grover, G.J., Mackenzie, J.W., and Weiss, H.R. 1990a. Regional oxygen supply and consumption balance in experimental left ventricular hypertrophy. Basic Res. Cardiol. 85: 575-584.
17. Scholz, P.M., Upsher, M.E., Eliades, D., Kedem, J., and Weiss, H.R. 1990b. Alterations in the regional β adrenergic system in experimental left ventricular hypertrophy. Cardiovasc. Res. 24: 65-71.
18. 2 consumption in experimental left ventricular hypertrophy: effect of negative inotropes. Life Sci. 53: 1847-1858.
19. Schrammel, A., Behrends, S., Schmidt, K., Koesling, D., and Mayer, B. 1996. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50: 105.
20. Shah, A.M., Lewis, M.J., and Henderson, A.H. 1991. Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J. Mol. Cell. Cardiol. 23: 55-64.
21. 2+ in intact cardiac myocytes. Circ. Res. 74: 970-978.
22. Sherman, A.J., Davis, C.A., Klocke, F.J., Harris, K.R., Srinivasan, G., Yaacoub, A.S., Quinn, D.A., Ahlin, K.A., and Jang, J.J. 1997. Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation, 95: 1328-1334.
23. Sink, J.D., Attarian, D.E., Chitwood, W.R., Hill, R.C., Pelleham, G.L., and Wechsler, A.S. 1980. An improved technique for producing ventricular hypertrophy with a subcoronary valvular aortic stenosis. Ann. Thorac. Surg. 30: 285-290.
24. Smith, J.A., Shah, A.M., and Lewis, M.J. 1991. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol. (London), 439: 1-14.
25. Thakkar, J., Tang, S.B., Sperelakis, N., and Wahler, G.M. 1988. Inhibition of cardiac slow action potentials by 8-bromo-cyclic GMP occurs independent of changes in cyclic AMP levels. Can. J. Physiol. Pharmacol. 66: 1092-1095.
26. Tohse, N., and Sperelakis, N. 1991. Cyclic GMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ. Res. 69: 325-331.
27. Wahler, G.M., and Dollinger, S.J. 1995. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 268: C45-C54.
28. Wahler, G.M., and Sperelakis, N. 1985. Intracellular injection of cyclic GMP depresses cardiac slow action potentials. J. Cyclic Nucleotide Protein Phosphorylation Res. 10: 83-95.
29. Wahler, G.M., Rusch, N.J., and Sperelakis, N. 1990. 8-Bromo-cyclic GMP inhibits the calcium channel current in embryonic chick ventricular myocytes. Can. J. Physiol. Pharmacol. 68: 531-534.
30. 4-induced cardiac hypertrophy. Am. J. Physiol. 268: H686-H691.
31. Wright, C.C., Kedem, J., Weiss, H.R., Rodriguez, E., Wong, J., Mackenzie, J.W., and Scholz, P.M. 1991. Relationship between adenylate cyclase activity and regional myocardial energetics in experimental left ventricular hypertrophy. J. Surg. Res. 50: 537-544.